Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-20-002419
Date:2020-01-06
Issuer: ADAPTIVE BIOTECHNOLOGIES CORP (ADPT)
Original Submission Date:

Reporting Person:

HILL NANCY LOUISE
C/O ADAPTIVE BIOTECHNOLOGIES CORP.
SUITE 200 SEATTLE, WA 98102

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-01-06 M 60,000 a $0.84 70,000 direct
COMMON STOCK 2020-01-06 S 60,000 d $29.14 10,000 direct
COMMON STOCK 2020-01-06 0 $0.00 500 indirect
COMMON STOCK 2020-01-06 0 $0.00 400 indirect
COMMON STOCK 2020-01-06 0 $0.00 300 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 0.84 2020-01-06 deemed execution date M 60,000 (d) 2023-11-03 common stock 60,000 $0.84 140,000 direct
Footnotes
IDfootnote
f1 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on december 5, 2019.
f2 the price reported for this transaction is a weighted-average price. the shares were sold in multiple transactions ranging from $28.55 to 29.48, inclusive. the reporting person undertakes to provide to adaptive biotechnologies corporation, any security holder of adaptive biotechnologies corporation, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this form 4.
f3 the reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
f4 the option is fully vested and exercisable.
WhaleWisdom Logo

Elevate your investments